Wisconsin Alumni Research Foundation

Advancing drug discovery beyond animal testing
8.3.26 | News & Announcements
Six projects selected for WARF/MilliporeSigma Challenge Grant CONTACT: Jeanan Yasiri Moe Director of Strategic Communications and Public Affairs [email protected] | (608) 960-9892 MADISON, Wis. – What if scientists could predict how...

Read More

Read More
WARF names Goutham Narla as Chief Scientific Officer of WARF Therapeutics
4.20.26 | News & Announcements
Physician-scientist and drug discovery leader to guide next phase of translational medicine program CONTACT: Jeanan Yasiri Moe Director of Strategic Communications and Public Affairs [email protected] | (608) 960-9892 MADISON, Wis....

Read More

Read More

WARF Advances in Clean Tech | May 2025

WARF ADVANCES Top licensing prospects from the University of Wisconsin-Madison High Yields of Paracetamol from Biomass-Derived P-Hydroxybenzoic Acid and P-Hydroxybenzamide UW-Madison researchers developed an inexpensive, high yielding method to synthesize…

Read More

Capturing attention

Bu Wang didn’t necessarily set out to launch a carbon-capture company that would attract millions of dollars from major climate-focused investment firms. Back in the pre-pandemic days of 2019, the…

Read More

WARF